Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q1 2024 · 10-Q
Revenue—
Net Income-$2.45M-$2.45MN/M vs Q1 2023 EPS Diluted-$0.70-$0.70N/M vs Q1 2023 Operating Income-$2,460,103N/M Operating Cash Flow-$3,064,249N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Mar 31, 2024 · filed May 15, 2024 · 45 d after period end